Rockwell Medical, Inc.
RMTI
$0.95
$0.00-0.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.93M | 16.07M | 18.91M | 24.67M | 28.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.93M | 16.07M | 18.91M | 24.67M | 28.32M |
| Cost of Revenue | 13.66M | 13.57M | 15.87M | 21.03M | 22.08M |
| Gross Profit | 2.27M | 2.50M | 3.04M | 3.63M | 6.24M |
| SG&A Expenses | 3.86M | 3.85M | 4.40M | 4.15M | 4.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.51M | 17.42M | 20.27M | 25.18M | 26.38M |
| Operating Income | -1.58M | -1.35M | -1.36M | -519.00K | 1.94M |
| Income Before Tax | -1.75M | -1.49M | -1.52M | -756.00K | 1.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.75M | -1.49M | -1.52M | -756.00K | 1.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.75M | -1.49M | -1.52M | -756.00K | 1.66M |
| EBIT | -1.58M | -1.35M | -1.36M | -519.00K | 1.94M |
| EBITDA | -1.04M | -786.00K | -821.00K | 24.00K | 2.48M |
| EPS Basic | -0.05 | -0.05 | -0.04 | -0.03 | 0.05 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.01 | 0.03 |
| EPS Diluted | -0.05 | -0.05 | -0.04 | -0.03 | 0.04 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.01 | 0.03 |
| Average Basic Shares Outstanding | 36.02M | 34.31M | 34.11M | 32.88M | 31.55M |
| Average Diluted Shares Outstanding | 36.02M | 34.31M | 34.11M | 32.88M | 32.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |